Box score
Ancilia Biosciences, Inc.
Reported $10.1M sold in a new Form D filed April 6, 2026 (New York, New York).
- Biggest raise
- $10.1M filed Apr 6, 2026
- League
- Open Other
- Based in
- New York, New York
- Season rank
- #271 of 2,435 in the Open League; #1736 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-04-06 | New notice | $10.1M | $10.1M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1975776.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Orkora Inc. rookie | Open | $10.2M |
| 2 | Definition II-A LLC | Open | $10.2M |
| 3 | Definition Opportunity XI LLC rookie | Open | $10.1M |
| 4 | EAG Holdings LP | Open | $10M |
| 5 | FPF Defense, Inc. rookie | Open | $10M |
| 6 | Definition Opportunity IA LLC | Open | $10M |